Epithalon 10MG

Epithalon (also known as Epitalon) is a synthetic tetrapeptide used in laboratory research to study telomere biology, peptide signaling, and related cellular pathways in controlled experimental systems. This product is supplied strictly for research use only. It is not approved or intended for human or animal use, and any discussion of biological activity refers only to preclinical or in vitro research.

Epithalon has attracted significant interest within the fields of aging biology and molecular research due to its observed interactions with telomerase activity and telomere dynamics in controlled experimental models. Telomeres are repetitive nucleotide sequences located at the ends of chromosomes that function as protective structures, maintaining chromosomal stability during successive cellular divisions. Progressive telomere shortening has been consistently associated with cellular senescence and replicative limits in a wide range of in vitro and experimental studies.

Experimental investigations involving Epithalon have primarily focused on its molecular signaling properties, gene expression modulation, and chromosomal endpoint behavior under laboratory conditions. These findings are derived from controlled research environments and are intended solely to advance scientific understanding of cellular aging mechanisms and peptide–DNA interactions.

Epithalon supplied for research applications is typically manufactured to high purity standards and is characterized as an LPS-free peptide, endotoxin-free peptide, and research peptide endotoxin tested to ensure suitability for sensitive laboratory assays, cellular studies, and biochemical analysis. These quality attributes are critical for minimizing experimental interference and maintaining data integrity in research settings.

Importantly, Epithalon is not approved for medical, veterinary, or dietary use. All discussion surrounding this compound pertains strictly to laboratory, cellular, or experimental research settings. No claims are made regarding therapeutic outcomes, enhancement of human health, or clinical efficacy.

Certificate of Analysis

wasp-facilities–032026-apBwsI (1)